ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 175 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,996 | +17.7% | 6,732 | +52.3% | 0.04% | +50.0% |
| Q2 2023 | $203,895 | -79.9% | 4,420 | -68.4% | 0.03% | -82.9% |
| Q1 2022 | $1,015,000 | +42.4% | 13,982 | +87.0% | 0.18% | +41.1% |
| Q2 2021 | $713,000 | +216.9% | 7,478 | +277.9% | 0.12% | +313.3% |
| Q1 2021 | $225,000 | -85.6% | 1,979 | -82.5% | 0.03% | -85.3% |
| Q4 2020 | $1,567,000 | +15.9% | 11,317 | -31.2% | 0.20% | +17.9% |
| Q3 2020 | $1,352,000 | +37.0% | 16,450 | -25.9% | 0.17% | +32.1% |
| Q1 2020 | $987,000 | -14.4% | 22,207 | -17.7% | 0.13% | -31.4% |
| Q4 2019 | $1,153,000 | – | 26,995 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
| First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
| SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
| Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
| Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
| Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
| FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
| Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
| Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
| Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |